Gewinn- und Verlustrechnung von Pediatrix Medical Group, Inc.

ATLANTA--(BUSINESS WIRE)--HB Wealth, one of the nation's largest independent, fee-only registered investment advisers, today announced that Steven D. Podnos, MD, MBA, CFP®, Rachel Podnos O'Leary, JD, CFP®, and Lauren Podnos-Garner, CFP®, have joined the firm. Together, the three advisors establish the firm's presence in Austin, Texas, with Rachel and Lauren based in Austin and Steven dividing his time between Austin and Cocoa Beach, Florida. The trio previously operated Wealth Care LLC, an inde.

MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.

Engineers Gate Manager LP trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE: MD) by 60.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 49,871 shares of the company's stock after selling 77,533 shares during the quarter. Engineers Gate Manager LP

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Sinopharm Group (OTCMKTS:SHTDY - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen's TEZSPIREÂ (te

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.